Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Cancer Res. 2021 Jul 28;81(19):5033–5046. doi: 10.1158/0008-5472.CAN-21-1027

Table.1.

Summary of the immunophenotype of Idh2R140Q/NHD13 mice

Mouse ID IHC Flow surface markers Flow DN1/DN2 markers TCRB V-DJ rearrangements TCRB D-J rearrangements Diagnosis
CD4 CD8 CD3 CD19 B220 Mac1 cKit CD25 CD44 CD90
524 CD3+ - - - - - - low + + + - D1J1S3 DN2 ALL
525 CD3+ - - - - - - + - + - - D1J1S3, D1J1S6, D2J2S4 DN1 ALL
526 CD3+ - - - - - - low + + + - D1J1S1 DN2 ALL
531 CD3+ - - - - - - low - + - - GL DN1 ALL
546 CD3+ - - + NT - - low low + low - D1J1S3 DN1/DN2 ALL
550 CD3+ - - + - - - - - + + - GL DN1 ALL
555 CD3+ - - - - - - low - + - - D1J1S2, D1J1S5 DN1 ALL
559 CD3+ - - - - - - + - + + - D1J1S2 DN1 ALL
570 NT - - - - low + - - + - - GL Immature AML
590 NT - - - - - + - - + - - GL AML
662 NT - - - - - + low low + + NT Thymus-D1J1S3, D1J1S6, D2J2S4, Spleen- D2J2S4 DN1/DN2 lymphoma
664 NT - - - - - + low low low + - Thymus- D1J1S1, D1J1S3, Spleen- D1J1S1 DN2 lymphoma
668 NT - - - - - - low + low + NT Thymus-D1J1S4 (major clone), D1J1S3, D1J1S6, D2J2S2 (minor clone) DN2 lymphoma

NT: not tested